Zahed Subhan work email
- Valid
- Valid
Zahed Subhan personal email
•Pharmaceutical and biopharmaceutical development and commercialization executive with more than 25 years experience in multinational and emerging pharmaceutical companies.•Extensive experience in drug discovery, clinical development, sales, marketing (including major drug launches), biopharmaceutical company start up and financing (seed, grants, venture capital), business development, licensing, alliance management and M&A.•Experienced in gaining regulatory approvals from FDA and EMA agencies.•Outstanding communication, presentation, teaching and negotiation skills.•Drexel University Professor; former University of North Carolina System Professor
-
ProfessorDrexel UniversityPhiladelphia, Pa, Us -
Executive Chairman, Co-Founder And DirectorEppin Pharma Inc. Dec 2019 - Present
-
ProfessorDrexel University Aug 2015 - Present
-
Co-Founder, DirectorAestas Pharma Inc. Dec 2015 - PresentLewisville, Nc, UsAestas Pharma Inc. is a pioneering biopharmaceutical company dedicated to the development of novel diagnostic imaging and therapeutic agents to enable the early detection and reversal of severely debilitating Alzheimer’s disease (AD). In marked contrast to competitor approaches, including current development stage drugs and diagnostics, Aestas is focused on targeting the very earliest stages of AD when clinical signs are not yet pronounced. AbVid is the company's lead product and is a first in class PET Neuroimaging agent capable of identifying "pre-clinical" AD in advance of significant plaque formation, or neuronal loss. The company is developing AbVid both for patient use and clinical trial use with investigational drugs in development for AD and other neurodegenerative diseases. -
Co-Founder, Director, CeoEppin Pharma Inc Jul 2013 - Nov 2019Director of emerging biopharmaceutical company focused on the development of a first in class non-hormonal oral, reversible male contraceptive. Candidate compounds inhibit eppin-SEMG interaction and mimic anti-eppin, effectively inhibiting sperm motility.
-
Advisory Council MemberNorth Carolina Biotechnology Center (Western North Carolina Region) Nov 2011 - Jul 2015Research Triangle Park, Nc, Us -
ProfessorWestern Carolina University (A University Of North Carolina Constituent Institution) Aug 2011 - Jul 2015Cullowhee, Nc, UsMember of faculty with broad academic responsibilities including responsibility for development and delivery of Healthcare Innovation Management program (Mission Health System, NC). -
Member Of The Board Of DirectorsArbovax Inc Aug 2011 - Jun 2014Member of the board of directors of Arbovax Inc., developing unique technology to modify arthropod-borne viruses (arboviruses) preventing replication in mammalian cells.
-
Chief Business Officer (Consulting)Melior Discovery 2006 - Aug 2011Exton, Pa, UsHead of Business Development & Marketing for dual preclinical CRO and emerging drug development company focused on metabolic disease and CNS therapeutic areas. -
CeoMarillion Pharmaceuticals Inc Feb 2006 - 2011Assisted academic founders at the University of Pennsylvania with formation and financing of University of Pennsylvania start up company, with focus on cancer drug/diagnostic development.•Developed first in class receptor targeted therapeutic agent for the treatment of hormone resistant prostate cancer and advanced metastatic breast cancer (receptor targeted therapeutic agent with potential superiority vs. Zevalin® and Bexxar®). •Successfully advanced development through IND and phase II clinical trials. •Completed seed, series A and follow-on financing from venture capital investors to fund development activities.
-
CeoNuevolution A/S Aug 2003 - Dec 2005Chief Executive Officer of emerging biopharmaceutical company focused on "DNA-directed" synthesis of small molecule drug candidates using proprietary "Chemetics" technology platform.•Advanced early stage platform technology to generate pre-clinical drug candidates as potential cancer and CNS therapeutics raising $18MM in VC funding.Company acquired by Amgen
-
Vp Business Development & MarketingLocus Pharmaceuticals Aug 2001 - Jul 2003UsResponsible for worldwide business development for emerging US drug Discovery Company focused on CNS, cancer and inflammation (structure based drug design technology platform). -
Chief Business OfficerGemini Genomics Mar 1997 - Feb 2001Westborough, Massachusetts, UsResponsible for worldwide business development & licensing, technology transfer and patents/IP management for EU and US based Genomics/Clinical Genetics Company with emphasis on disease gene identification.•Negotiated licensing and research collaborations with major healthcare and pharmaceutical companies in US, EU and Japan.•Key member of Executive Management Team achieving $100 MM IPO on NASDAQ stock exchange and $220 MM trade sale to Sequenom Inc. (CA, USA). -
European Marketing Director; Head Of Sales And Marketing, Head Of Business DevelopmentDupont Merck Pharmaceuticals Company (Acquired By Bristol-Myers Squibb Jan 1991 - Feb 1997Us•Launched major pharmaceutical brands including Celexa® (depression), Sinemet® CR® (Parkinson's disease), Tiazac® (angina), Zestril® (hypertension).•Leadership of professional business development, and marketing teams, including sales, professional (medical) relations, alliance management, licensing, product management, marketing planning, marketing communications and marketing research specialists.•Recruited, trained and developed field sales and professional relations teams to achieve corporate revenue and earnings objectives. -
Product Manager - Imitrex®Glaxowellcome Jan 1988 - Jan 1991Brentford, Middlesex, GbLaunched first in class treatment for migraine: Imitrex® (sumatriptan). -
Clincal Research Manager; Sales RepresentativeSanofi-Aventis Jan 1985 - Jan 1988Paris, France, FrCoordinated phase II/III neurology (epilepsy) clinical drug development programs to FDA requirements. -
Clinical Trials CoordinatorUniversity Of Leeds Aug 1980 - Jan 1985Leeds, West Yorkshire, Gb•Supervised conduct of phase I-II clinical trials in pharmaceutical industry sponsored university based clinical pharmacology unit.•Completed doctorate (PhD) in Pharmacology. Published 30 articles in peer reviewed academic journals.
Zahed Subhan Skills
Zahed Subhan Education Details
-
University Of LeedsPharmacology -
Bradford University School Of Management, UkMarketing & Strategic Management
-
University Of LondonLaw
-
Aston University, UkApplied Experimental Psychology And Neuroscience
-
University Of SunderlandPharmacology
Frequently Asked Questions about Zahed Subhan
What company does Zahed Subhan work for?
Zahed Subhan works for Drexel University
What is Zahed Subhan's role at the current company?
Zahed Subhan's current role is Professor.
What is Zahed Subhan's email address?
Zahed Subhan's email address is zs****@****wcu.edu
What schools did Zahed Subhan attend?
Zahed Subhan attended University Of Leeds, Bradford University School Of Management, Uk, University Of London, Aston University, Uk, University Of Sunderland.
What skills is Zahed Subhan known for?
Zahed Subhan has skills like Biotechnology, Commercialization, Drug Development, Biopharmaceuticals, Entrepreneurship, Management, Life Sciences, Pharmaceutical Industry, Marketing, Business Development, Cancer, Drug Discovery.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial